Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/8/2020
SIETES contiene 93083 citas

 
 
 1 a 20 de 32 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Douros A, Lix LM, Fralick M, Shah BR, Ronksley PE, Tremblay E, Hu N, Alessi-Severini S, Fisher A, Bugden SC, Ernst P, Filion KB, for the Canadian Network of Observational Drug Effect Studies (CNODES) Investigators. Sodium–glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis A multicenter cohort study. Ann Intern Med 2020:28 de julio. [Ref.ID 103685]
5. Cita con resumen
Evans I, Penman I, Turner N, Dhaun N. NSAIDs and nephrocalcinosis. Eur J Clin Pharmacol 2013;69:2103-4. [Ref.ID 96641]
6. Cita con resumen
Anónimo. Acide carglumique et acidémies organiques. Trop faible niveau d'évaluation. Prescrire 2012;32:813. [Ref.ID 93973]
7. Cita con resumen
Colman E, Golden J, Roberts M, Egan A, Weaver J, Rosenbraugh C. The FDA's assessment of two drugs for chronic weight management. N Engl J Med 2012;367:1577-9. [Ref.ID 93939]
8. Cita con resumen
Kane B, Turkington PM, Howard LS, Davison AG, Gibson GJ, O'Driscoll BR. Rebound hypoxaemia after administration of oxygen in an acute exacerbation of chronic obstructive pulmonary disease. BMJ 2011;342:823-4. [Ref.ID 90379]
9.
Liamis G, Milionis HJ, Elisaf M. Pharmacologically-induced metabolic acidosis: a review. Drug Saf 2010;33:371-91. [Ref.ID 88433]
10. Cita con resumen
Mirza N, Marson AG, Pirmohamed M. Effect of topiramate on acid-base balance: extent, mechanism and effects. Br J Clin Pharmacol 2009;68:655-61. [Ref.ID 87157]
11. Cita con resumen
Mcque K. FDA warns of metabolic acidosis risk with anti-epileptic zonisamide. Scrip 2009;3435:22. [Ref.ID 85454]
12. Cita con resumen
Dhatariya KK. Diabetic ketoacidosis. BMJ 2007;334:1284-5. [Ref.ID 80421]
13. Cita con resumen
Moore FA, McKinley B, Moore EE. The next generation in shock resuscitation. Lancet 2004;363:1988-96. [Ref.ID 70368]
14.
Anónimo. Acidose métabolique due au topiramate. Prescrire 2004;24:352. [Ref.ID 69913]
15. Cita con resumen
Anónimo. Topiramate. Warning about metabolic acidosis. WHO Pharmaceuticals Newsletter 2004;1:8. [Ref.ID 69607]
16. Cita con resumen
Anónimo. Metabolic acidosis risk with Topamax. Scrip 2004;2915:24. [Ref.ID 68653]
17. Cita con resumen
Palmer ME, Haller C, McKinney PE, Klein-Schwartz W, Tschirgi A, Smolinske SC, Woolf A, Sprague BM, Ko R, Everson G, Nelson L S, Dodd-Butera T, Bartlett WD, Landzberg BR. Adverse events associated with dietary supplements: an observational study. Lancet 2003;361:101-6. [Ref.ID 64778]
18.Tiene citas relacionadas
Daugirdas JT. Peritoneal dialysis in acute renal failure - why the bad outcome?. N Engl J Med 2002;347:933-5. [Ref.ID 63429]
19.Tiene citas relacionadas
Phu N H, Hien TT, Mai NTH, Chau TTH, Chuong LV, Loc PP, Winearls C, Farrar J, White N, Day N. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002;347:895-902. [Ref.ID 63425]
20.
Anónimo. Propofol: reactions to long-term high doses. WHO Drug Information 2001;15:17-8. [Ref.ID 58809]
Seleccionar todas
 
 1 a 20 de 32 siguiente >>